**Abstract**

Ca~v~2.3 (R-type) voltage-activated Ca^2+^ channels (VACCs), encoded by the *CACNA1E* gene, are responsible for transmission of somatic inflammatory pain, and activation of antinociception elicited by visceral inflammatory pain stimuli. The rs3845446 single-nucleotide polymorphism (SNP) of the *CACNA1E* gene is an intronic Tag SNP in the linkage disequilibrium block from intron 46 to exon 47, a region that contains a stop codon. Carriers of the minor G allele of the rs3845446 SNP had less opioid requirements for controlling pain after orthognathic surgery, suggesting that this SNP downregulates Ca~v~2.3 VACCs functions responsible for transmission of somatic inflammatory pain. Unknown is whether this SNP influences pain-related phenotypes after splanchnic organ surgery involving both somatic and visceral inflammatory pain, where visceral inflammatory pain stimuli should activate Ca~v~2.3 VACC-mediated antinociception. In the present study, two groups of patients who underwent gastrointestinal surgery were examined. Group 1 included 351 patients who underwent laparoscopic colectomy and postoperative intravenous patient-controlled analgesia with opioid. Group 2 included 112 patients who underwent open gastrectomy or open colectomy and postoperative continuous epidural analgesia. In both groups, patients with chronic pain or severe systemic disease, patients who took any analgesics, psychotherapeutic drugs, anti-anxiety drugs, or anticonvulsants were excluded. There was no difference in age, body height or weight between patients with or without the minor G allele of the rs3845336 SNP in both groups. Carriers of the minor G allele had higher opioid requirements in Group 1, while reporting higher pain scores in Group 2. Altogether, carriers of the minor G allele exhibited enhanced pain-related phenotypes after gastrointestinal surgery, in contrast to reduced pain-related phenotypes after orthognathic surgery. These results suggest that this SNP enhances pain-related phenotypes after gastrointestinal surgery, possibly through impairment of Ca~v~2.3 VACCs responsible for activation of visceral inflammatory pain stimulus-elicited antinociception.
